Correlations have also been observed in other cancers, such as prostate cancer, where genetic deletion of CBP and p300 results in the promotion or perturbation of tumourigenesis induced by phosphatase and tensin homologue (PTEN) deficiency [25, 26]. The gene discussed is EP300; the disease is prostate carcinoma.